Status:
TERMINATED
The Use of High Flow Nasal Cannula, Standard Face Mask and Standard Nasal Cannula in Morbidly Obese Patients
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Desaturation of Blood
Colonoscopy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
It is standard practice in the United States and many parts of world to perform Gastrointestinal endoscopy with the patient under deep intravenous sedation. Obesity is accepted as a patient specific r...
Detailed Description
The prevalence of morbid obesity is increasing worldwide. As the severity of obesity increases, the incidence of diagnosed obstructive sleep apnea also rises. Studies have shown an incidence of sleep ...
Eligibility Criteria
Inclusion
- Age between 18-80
- Subjects undergoing colonoscopies
- Morbidly obese BMI equal or greater than 40
- STOPBANG score equal or greater than 5
Exclusion
- Subjects deemed hemodynamically unstable by the anesthesia team
- Subjects who are an aspiration risk and will require endotracheal intubation.
- Pregnancy
- Subjects with an allergy to propofol
- Patients who are unable to tolerate the high flow nasal cannula secondary to discomfort
- Subjects unwilling to sign consent
- Patients that received medications other than lidocaine and propofol
Key Trial Info
Start Date :
March 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2023
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT03479905
Start Date
March 5 2018
End Date
September 20 2023
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkland Helath Hospital System
Dallas, Texas, United States, 75390